News

Boussard & Gavaudan Holding Limited: NAV Report

Boussard & Gavaudan Holding Limited: NAV Report

Overview of Boussard & Gavaudan Holding Limited

Boussard & Gavaudan Holding Limited is dedicated to delivering essential financial insights regarding its performance and stability within the investment sector. As a closed-ended investment firm, it operates under the supervision of the Guernsey Financial Services Commission, ensuring that shareholders receive timely and accurate information.

Current NAV Estimates

The company has recently calculated its Net Asset Values (NAVs) based on the close of business. For the latest reporting period, Boussard & Gavaudan Holding Limited has provided the following share estimations:

Breakdown of Estimated NAV

The estimated NAV is divided into Euro Shares and Sterling Shares:

Euro Shares: €28.6834

Sterling Shares: £25.6948

Performance Returns

Investors may find the estimated returns for the month-to-date (MTD), year-to-date (YTD), and since inception (ITD) particularly interesting:

  • Estimated MTD Return: 0.14% for Euro Shares and 0.17% for Sterling Shares.
  • Estimated YTD Return: 4.12% for Euro Shares and 4.58% for Sterling Shares.
  • Estimated ITD Return: 186.83% for Euro Shares and 156.95% for Sterling Shares.

All NAV and return calculations are net of management and performance fees, providing investors with a clear understanding of the company's performance metrics.

Market Information

Boussard & Gavaudan Holding Limited's shares are traded across various market exchanges, influenced by different market conditions. Here’s an overview of the recent market activity:

Market Close Prices

The closing prices for Euro and Sterling Shares are as follows:

  • Market Close for Euro Shares: €27.00 on Amsterdam (AEX)
  • Market Close for Sterling Shares: £2,200.00 on London Stock Exchange (LSE)

Analysis of Premium/Discount

Investors often evaluate the premium or discount relative to the estimated NAV to make informed decisions:

  • Euro Shares: Discount of -5.87%
  • Sterling Shares: Discount of -14.38%

Company Share Transactions

Below is a summary of the trading activity related to the company’s own securities that have been bought back into treasury:

Transaction Details

Key information regarding ordinary shares, Euro Shares, and Sterling Shares includes:

  • Number of Shares: N/A
  • Average Price: N/A
  • Range of Price: N/A

Liquidity Enhancement Agreement

To improve market liquidity, the company has put in place a Liquidity Enhancement Agreement:

Shares and Pricing Information

Important details regarding shares under this agreement are as follows:

  • Number of Shares: N/A
  • Average Price: N/A

BGHL Capital Structure

Boussard & Gavaudan Holding Limited provides crucial insights for investors regarding its overall capital structure:

Summary of BGHL Ordinary Shares

The company has a specific number of shares categorized as Euro and Sterling Shares:

  • Shares Outstanding: 12,299,516 (Euro Shares) and 123,090 (Sterling Shares)
  • Shares Issued: 12,299,516 (Euro Shares) and 123,090 (Sterling Shares)

Estimated BG Fund NAV

The NAV of the fund is vital for investors, especially concerning different share classes:

Class B and Class GBP A Shares

Estimates for these class shares are as follows:

  • Class B Euro Shares (estimated): €258.7789
  • Class GBP A Shares (estimated): £137.6593

These class shares do not incur investment manager fees, as the investment manager receives management and performance fees related to its role within BGHL.

Contact Information

For further insights and inquiries, you can reach out to Boussard & Gavaudan Investment Management, LLP as follows:

Emmanuel Gavaudan
Phone: +44 (0) 20 3751 5389
Email: info@bgam-uk.com

Frequently Asked Questions

1. What is the estimated NAV of Boussard & Gavaudan Holding Limited?

The estimated NAV for Euro Shares stands at €28.6834, while for Sterling Shares, it is £25.6948.

2. What are the recent performance returns?

The estimated MTD returns are 0.14% for Euro Shares and 0.17% for Sterling Shares, with YTD returns of 4.12% and 4.58%, respectively.

3. How do the market close prices affect Boussard & Gavaudan shares?

According to the latest reports, Euro Shares closed at €27.00, and Sterling Shares closed at £2,200.00.

4. What does the premium/discount to estimated NAV signify?

Currently, Euro Shares are at a discount of -5.87%, while Sterling Shares are at -14.38%. This information is crucial for understanding market valuations.

5. How can I contact Boussard & Gavaudan Investment Management?

For any inquiries, you can contact Emmanuel Gavaudan at +44 (0) 20 3751 5389 or via email at info@bgam-uk.com.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

OnTime's Bold Vision: Transforming Home Healthcare Admin

Updated Category News Views 7

Changing the Game for Home Healthcare Every now and then, an idea rolls in that speaks to a real need, and OnTime's push to soften the burdens of the home healthcare industry might just be one of those. Built from grassroots experience, they're dropping efforts to modernize the back-end monotony so healthcare workers can zero in on, well, healthcare. A Nose-Dive into...

Continue Reading
Image Analysis Group Unveils DYNAMIKA V.7 for Clinical Trials

Updated Category News Views 185

Introduction to DYNAMIKA V.7 by Image Analysis Group Image Analysis Group (IAG) has recently launched DYNAMIKA V.7, an advanced cloud platform tailored for clinical trial imaging. Following stringent audits and certifications, including SOC II Type I compliance and British Standards Institute (BSI) surveillance audit certification, this platform stands out in its field....

Continue Reading
Sanofi's Strategic Move to Enhance Adult Vaccination Pipeline

Updated Category News Views 95

Sanofi Strengthens Its Vaccination Portfolio Sanofi SA (NASDAQ: SNY) has made a significant step in the healthcare sector by acquiring Dynavax Technologies Corporation (NASDAQ: DVAX) for approximately $2.2 billion. This acquisition, which involves a cash purchase price of $15.50 per share, signals Sanofi's commitment to enhancing its capabilities in the adult immunization...

Continue Reading
Miral Impact Fund: A New Era for Community and Environment

Updated Category News Views 135

Introducing the Miral Impact Fund Miral has taken a significant step towards environmental stewardship and social responsibility by launching the Miral Impact Fund. This initiative, launched in partnership with the Authority of Social Contribution – Ma'an, aims to create a positive impact within communities by addressing pressing social issues while promoting...

Continue Reading
Class Action Update for Regeneron Pharmaceuticals Investors

Updated Category News Views 125

Class Action Lawsuit Overview for Regeneron Pharmaceuticals Levi & Korsinsky, LLP has announced that Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) investors should take note of a pending class action lawsuit concerning alleged securities fraud. Understanding the Class Action The lawsuit aims to recover losses for investors adversely affected by claims of fraud that...

Continue Reading